Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_provenance.
- NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_assertion description "[These results show for the first time that TGF-beta2, its receptors TGF-beta R1 and TGF-beta R2, and activator thrombospondin-1 are concordantly suppressed early in breast carcinogenesis by histone modifications and indicate that the TGF-beta signaling pathway is a novel target for gene activation by epigenetic therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_provenance.
- NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_assertion evidence source_evidence_literature NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_provenance.
- NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_assertion SIO_000772 18089780 NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_provenance.
- NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_assertion wasDerivedFrom befree-2016 NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_provenance.
- NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_assertion wasGeneratedBy ECO_0000203 NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_provenance.
- befree-2016 importedOn "2016-02-19" NP645921.RAYHY7FuMZJ_sy-p3P72l6Gd0ZUS-oNSPFW3HtmFKu3bc130_provenance.